---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-021882"
form_type: "8-K"
ticker: "RGBP"
cik: "0001589150"
company_name: "Regen BioPharma Inc"
filed_at: "2025-08-01T23:59:59+00:00"
generated_at: "2026-05-17T21:50:12.292622+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Regen Biopharma enters $130K convertible note financing with CFI Capital

## Summary
- Issued a 6% convertible promissory note for $130,000 principal; $13,000 original issue discount, net proceeds $117,000.
- Note matures July 28, 2026; interest payable in common stock at holder's option.
- Conversion price set at 60% of lowest trading price over prior 20 trading days on OTC Markets.
- Company reserved 15,700,485 common shares for conversion; holder must maintain 5x coverage reserve.

## SEC filing metadata
- accession: 0001641172-25-021882
- form_type: 8-K
- ticker: RGBP
- cik: 0001589150
- company_name: Regen BioPharma Inc
- filed_at: 2025-08-01T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1589150/000164117225021882/0001641172-25-021882-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1589150/000164117225021882/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-021882
- JSON: https://secwatch.observer/filing/0001641172-25-021882.json
- Plain text: https://secwatch.observer/filing/0001641172-25-021882.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.